Long-Term Clinical Outcomes of Severe Combined Immunodeficiency Patients Given Nonablative Marrow Transplants
- 1 April 2022
- journal article
- research article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (4) , 1077-1083
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- B-cell function in severe combined immunodeficiency after stem cell or gene therapy: A reviewJournal of Allergy and Clinical Immunology, 2010
- Long-term Clinical Outcome of Patients with Severe Combined Immunodeficiency Who Received Related Donor Bone Marrow Transplants without Pretransplant Chemotherapy or Post-transplant GVHD ProphylaxisThe Journal of Pediatrics, 2009
- Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiencyBlood, 2007
- Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complicationsBlood, 2006
- Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioningBone Marrow Transplantation, 2004
- Bone marrow transplantation for T−B− severe combined immunodeficiency disease in Athabascan-speaking native AmericansBone Marrow Transplantation, 2001
- Dental manifestations in severe combined immunodeficiency following bone marrow transplantationBone Marrow Transplantation, 2000
- Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1999
- Treatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine DeaminaseNew England Journal of Medicine, 1987